Goldman Sachs’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,076
| Closed | -$885K | – | 5128 |
|
|
2025
Q1 | $885K | Buy |
10,076
+1,094
| +12% | +$96.1K | ﹤0.01% | 3890 |
|
|
2024
Q4 | $833K | Buy |
8,982
+4,382
| +95% | +$406K | ﹤0.01% | 4020 |
|
|
2024
Q3 | $337K | Buy |
4,600
+2,001
| +77% | +$146K | ﹤0.01% | 4297 |
|
|
2024
Q2 | $151K | Buy |
+2,599
| New | +$151K | ﹤0.01% | 4431 |
|
|
2022
Q1 | – | Sell |
-536
| Closed | -$221K | – | 5744 |
|
|
2021
Q4 | $221K | Buy |
+536
| New | +$221K | ﹤0.01% | 4937 |
|
|
2021
Q3 | – | Sell |
-2,993
| Closed | -$2.39M | – | 5344 |
|
|
2021
Q2 | $2.39M | Buy |
+2,993
| New | +$2.39M | ﹤0.01% | 3362 |
|